Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BPR1J-097, a new-type small molecule FLT-3 inhibitor(IC50=11±7 nM), is with great anti-tumor activities in vivo.
説明 | BPR1J-097, a new-type small molecule FLT-3 inhibitor(IC50=11±7 nM), is with great anti-tumor activities in vivo. |
ターゲット&IC50 | FLT3 (D835Y):3 nM, FLT3:11±7 Nm, MOLM-13 and MV4-11 cells:21±7 and 46±14 nM |
In vivo | In FLT3-driven AML murine xenograft models, BPR1J-097 inhibited FLT3/signal transducer and activator of transcription 5 phosphorylation and triggered apoptosis in FLT3-driven AML cells and pronounced dose-dependent tumour growth inhibition and regression. |
キナーゼ試験 | Cells are treated with THZ531 for 6 hours.After treatment cells are washed 2-fold with cold PBS and then lysed in the following lysis buffer: Hepes(50 mM, pH 7.4), NaCl(150 mM), 1% Nonidet P40 substitute, EDTA(5 mM), DTT(1 mM), and protease/phosphatase cocktails.Lysates are treated with bio-THZ1 or bio-TH531 for pulldown overnight at 4°C. |
分子量 | 553.07 |
分子式 | C27H29ClN6O3S |
CAS No. | T4261 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.53 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BPR1J-097 hydrochloride (1327167-19-0(free base)) T4261 Angiogenesis Tyrosine Kinase/Adaptors FLT BPR1J 097 hydrochloride (1327167 19 0(free base)) BPR-1J-097 hydrochloride (1327167-19-0(free base)) BPR1J097 hydrochloride (1327167190(free base)) Inhibitor inhibitor inhibit